Life Couriers Partners with Orchestra Life Sciences

Life Couriers partners with Orchestra Life Sciences to strengthen global supply chain for Cell and Gene Therapies and Radiopharmaceuticals.

Life Couriers Partners with Orchestra Life Sciences to Strengthen Global Supply Chain for Cell and Gene Therapies and Radiopharmaceuticals

(Munich, 18th September 2024) — Life Couriers, the global leader in specialized healthcare logistics, is proud to announce a strategic partnership with Orchestra Life Sciences, a leading technical consultancy supporting clients in cell and gene therapy and radiopharmaceuticals, to enhance supply chain capabilities for the distribution of advanced cell and gene therapies (CGTs) and radiopharmaceuticals. This partnership will expand access to critical treatments by improving delivery times, ensuring product integrity, and increasing overall efficiency in the supply chain.

As the healthcare industry continues to make advancements towards more personalized medicines, the ability to deliver novel life-saving treatments to patients swiftly and securely has become a top priority. By collaborating with Orchestra Life Sciences, Life Couriers aims to address supply chain challenges and ensure that patients receive their therapies on time, when they need them the most.

“At Life Couriers, we understand that the success of advanced therapies hinges on the speed and precision of delivery,” said Matt Silverberg, CCO of Life Couriers. “This partnership with Orchestra Life Sciences allows us to leverage our global logistics expertise to ensure that life-saving treatments are available to patients without delay. Our mission is to provide confidence and certainty along every step of the value chain, and this collaboration is a testament to that commitment.”

With Life Couriers’ industry-leading logistics infrastructure and Control Towers, offering real-time monitoring and oversight 24/7/365, the partnership will streamline the transportation of CGTs and radiopharmaceuticals from developers to patients, addressing the unique challenges associated with these therapies. This includes managing the short half-lives of radiopharmaceuticals, which require swift and accurate delivery to maintain their efficacy.

“The supply chain is a critical pillar in ensuring the success of advanced therapies, especially in the cell, gene, and radiopharmaceutical space. Time to treatment is vital for these patients, and any delay can be life-altering,” said Emilie Pelletier, CEO of Orchestra Life Sciences. “Our partnership with Life Couriers strengthens our ability to deliver life-saving therapies efficiently and reliably. By expanding access to these treatments and meeting patients where they are, we can make a significant impact on their outcomes and provide hope to those facing serious conditions.”

The collaboration will help bridge gaps in the global supply chain, broaden access to support critical clinical trial programs, particularly for autologous cell therapies that could potentially improve regulatory outcomes and support expanded access programs. Together, Life Couriers and Orchestra Life Sciences are advancing the future of cancer treatment by delivering cutting-edge therapies to patients worldwide.

Press Contact

Name: Tom Wells
Email: [email protected]

About Life Couriers

Life Couriers is an international group of specialized logistics service operators focused on life science and healthcare logistics. The group offers the broadest service portfolio on the market through six business segments: Stem Cell Onboard, Radiopharma, Life Science, Direct-to-Patient, Pharma Freight and Emergency Logistics. With locations in the US, UK, Germany, France, Belgium, Czech Republic, Italy, Sweden, Romania, Austria, Denmark, Mexico, Switzerland & Honduras, Life Couriers has a worldwide reach.

Life Couriers is operated by SLS Group GmbH, headquartered in Munich, Germany, and is led by Stefan Glebke as CEO. The group currently employs over 750 people worldwide. In 2023, Life Couriers generated a turnover of €230m.

About Orchestra Life Sciences

Orchestra Life Sciences is a technical consultancy supporting clients in cell and gene therapy and radiopharmaceuticals. As the premier consultancy in advanced therapies, Orchestra Life Sciences assists clients with all facets of business strategy, production, supply chain, logistics, capital projects and operations.

With a focus on innovation and patient-centered care, Orchestra Life Sciences partners with leading organizations to bring novel treatments to market, improve patient outcomes, and expand access to life-saving therapies globally.